Loading…

DDD Pacemakers Maximize Hemodynamic Benefits and Minimize Complications for Most Patients

A 44‐month retrospective analysis was performed on 666 pacemakers implanted at Mt. Sinai Medical Center. Mapping techniques and endocardial waveform analyses were used during lead positioning to ensure the best electrical environment. The optimal pacing lead type was selected based on the clinical s...

Full description

Saved in:
Bibliographic Details
Published in:Pacing and clinical electrophysiology 1988-11, Vol.11 (11), p.1911-1916
Main Authors: BYRD, CHARLES L., SCHWARTZ, SUSAN J., GONZALES, MICHELE, BYRD, CHARLES B., CIRALDO, ROBERT J., SIVINA, MANUEL, YAHR, WILLIAM Z., GREENBERG, JACK J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4091-6a6c397aace86686d4286b742bd29558cc90b8bd8b2eb06b525778bc69028e243
cites cdi_FETCH-LOGICAL-c4091-6a6c397aace86686d4286b742bd29558cc90b8bd8b2eb06b525778bc69028e243
container_end_page 1916
container_issue 11
container_start_page 1911
container_title Pacing and clinical electrophysiology
container_volume 11
creator BYRD, CHARLES L.
SCHWARTZ, SUSAN J.
GONZALES, MICHELE
BYRD, CHARLES B.
CIRALDO, ROBERT J.
SIVINA, MANUEL
YAHR, WILLIAM Z.
GREENBERG, JACK J.
description A 44‐month retrospective analysis was performed on 666 pacemakers implanted at Mt. Sinai Medical Center. Mapping techniques and endocardial waveform analyses were used during lead positioning to ensure the best electrical environment. The optimal pacing lead type was selected based on the clinical situation. Follow‐up evaluations were rigorous. Patient population ranged in age from 28 to 103 with a mean of 78 years at time of implant. Seventy percent of the patients received DDD pacemakers with an 81% survival incidence at 44 months, of the WI population (30% of the implants), there was a 62% survival incidence. Most problems associated with the pacing systems were related to the atrial channel. Loss of atrial sensing occurred in 7.5% of the population and was corrected noninvasively in 5.8%. Due to chronic loss of atrial sensing, 1.7% of the population remained programmed to DVI/VVI. A total of 7.7% were chronically reprogrammed from DDD to WI, 5.6% secondary to atrial fibrillation. Reoperations were necessary in 1.2% of the malfunctioning systems that could not be corrected by reprogramming. The following conclusions were reached: (1) maximizing hemodynamic benefits and minimizing pacemaker complications permitted a survival rate equal to or better than that of the general population, and (2) chronic problems related to the atrial lead and malfunctions of the pacing system were minimized by careful patient selection, appropriate pacemaker and lead selection, endocardial waveform analysis, and thorough follow‐up.
doi_str_mv 10.1111/j.1540-8159.1988.tb06328.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78597613</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78597613</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4091-6a6c397aace86686d4286b742bd29558cc90b8bd8b2eb06b525778bc69028e243</originalsourceid><addsrcrecordid>eNqVkM1O4zAUhS0EgtLhEZAiFuwSbCf-YwVtgaJpZxhpEGJl2c6t5JKfEqeinacnVaruxxsvzrmfrz-ErghOSHdulglhGY4lYSohSsqktZinVCabIzQ4RMdogEkmYplKdYbOQ1hijDnO2Ck6pRlPGecD9D6ZTKIX46A0H9CEaG42vvT_IJpCWefbypTeRSOoYOHbEJkqj-a-6hvjulwV3pnW11WIFnUTzevQdrDWQ9WGH-hkYYoAF_t7iF4fH_6Op_Hs99Pz-H4WuwwrEnPDXaqE6VaQnEueZ1RyKzJqc6oYk84pbKXNpaXQ_dIyyoSQ1nGFqQSapUN03XNXTf25htDq0gcHRWEqqNdBC8mU4CTtird90TV1CA0s9KrxpWm2mmC986qXeidP7-TpnVe996o33fDl_pW1LSE_jO5Fdvldn3_5Arb_QdYv9-MHogjpEHGP8KGFzQFhmg_NRSqYfvv1pMnjT_5nOmIap9_iX5do</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78597613</pqid></control><display><type>article</type><title>DDD Pacemakers Maximize Hemodynamic Benefits and Minimize Complications for Most Patients</title><source>SPORTDiscus</source><creator>BYRD, CHARLES L. ; SCHWARTZ, SUSAN J. ; GONZALES, MICHELE ; BYRD, CHARLES B. ; CIRALDO, ROBERT J. ; SIVINA, MANUEL ; YAHR, WILLIAM Z. ; GREENBERG, JACK J.</creator><creatorcontrib>BYRD, CHARLES L. ; SCHWARTZ, SUSAN J. ; GONZALES, MICHELE ; BYRD, CHARLES B. ; CIRALDO, ROBERT J. ; SIVINA, MANUEL ; YAHR, WILLIAM Z. ; GREENBERG, JACK J.</creatorcontrib><description>A 44‐month retrospective analysis was performed on 666 pacemakers implanted at Mt. Sinai Medical Center. Mapping techniques and endocardial waveform analyses were used during lead positioning to ensure the best electrical environment. The optimal pacing lead type was selected based on the clinical situation. Follow‐up evaluations were rigorous. Patient population ranged in age from 28 to 103 with a mean of 78 years at time of implant. Seventy percent of the patients received DDD pacemakers with an 81% survival incidence at 44 months, of the WI population (30% of the implants), there was a 62% survival incidence. Most problems associated with the pacing systems were related to the atrial channel. Loss of atrial sensing occurred in 7.5% of the population and was corrected noninvasively in 5.8%. Due to chronic loss of atrial sensing, 1.7% of the population remained programmed to DVI/VVI. A total of 7.7% were chronically reprogrammed from DDD to WI, 5.6% secondary to atrial fibrillation. Reoperations were necessary in 1.2% of the malfunctioning systems that could not be corrected by reprogramming. The following conclusions were reached: (1) maximizing hemodynamic benefits and minimizing pacemaker complications permitted a survival rate equal to or better than that of the general population, and (2) chronic problems related to the atrial lead and malfunctions of the pacing system were minimized by careful patient selection, appropriate pacemaker and lead selection, endocardial waveform analysis, and thorough follow‐up.</description><identifier>ISSN: 0147-8389</identifier><identifier>EISSN: 1540-8159</identifier><identifier>DOI: 10.1111/j.1540-8159.1988.tb06328.x</identifier><identifier>PMID: 2463566</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Aged ; Aged, 80 and over ; atrial fibrillation ; Cardiac Pacing, Artificial - methods ; cummulative survival ; DDD pacemaker ; Female ; Follow-Up Studies ; Hemodynamics ; Humans ; loss of atrial sensing ; Male ; Middle Aged ; Pacemaker, Artificial - adverse effects ; pacing modality ; reprogramming ; Retrospective Studies ; Time Factors</subject><ispartof>Pacing and clinical electrophysiology, 1988-11, Vol.11 (11), p.1911-1916</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4091-6a6c397aace86686d4286b742bd29558cc90b8bd8b2eb06b525778bc69028e243</citedby><cites>FETCH-LOGICAL-c4091-6a6c397aace86686d4286b742bd29558cc90b8bd8b2eb06b525778bc69028e243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2463566$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BYRD, CHARLES L.</creatorcontrib><creatorcontrib>SCHWARTZ, SUSAN J.</creatorcontrib><creatorcontrib>GONZALES, MICHELE</creatorcontrib><creatorcontrib>BYRD, CHARLES B.</creatorcontrib><creatorcontrib>CIRALDO, ROBERT J.</creatorcontrib><creatorcontrib>SIVINA, MANUEL</creatorcontrib><creatorcontrib>YAHR, WILLIAM Z.</creatorcontrib><creatorcontrib>GREENBERG, JACK J.</creatorcontrib><title>DDD Pacemakers Maximize Hemodynamic Benefits and Minimize Complications for Most Patients</title><title>Pacing and clinical electrophysiology</title><addtitle>Pacing Clin Electrophysiol</addtitle><description>A 44‐month retrospective analysis was performed on 666 pacemakers implanted at Mt. Sinai Medical Center. Mapping techniques and endocardial waveform analyses were used during lead positioning to ensure the best electrical environment. The optimal pacing lead type was selected based on the clinical situation. Follow‐up evaluations were rigorous. Patient population ranged in age from 28 to 103 with a mean of 78 years at time of implant. Seventy percent of the patients received DDD pacemakers with an 81% survival incidence at 44 months, of the WI population (30% of the implants), there was a 62% survival incidence. Most problems associated with the pacing systems were related to the atrial channel. Loss of atrial sensing occurred in 7.5% of the population and was corrected noninvasively in 5.8%. Due to chronic loss of atrial sensing, 1.7% of the population remained programmed to DVI/VVI. A total of 7.7% were chronically reprogrammed from DDD to WI, 5.6% secondary to atrial fibrillation. Reoperations were necessary in 1.2% of the malfunctioning systems that could not be corrected by reprogramming. The following conclusions were reached: (1) maximizing hemodynamic benefits and minimizing pacemaker complications permitted a survival rate equal to or better than that of the general population, and (2) chronic problems related to the atrial lead and malfunctions of the pacing system were minimized by careful patient selection, appropriate pacemaker and lead selection, endocardial waveform analysis, and thorough follow‐up.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>atrial fibrillation</subject><subject>Cardiac Pacing, Artificial - methods</subject><subject>cummulative survival</subject><subject>DDD pacemaker</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Hemodynamics</subject><subject>Humans</subject><subject>loss of atrial sensing</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Pacemaker, Artificial - adverse effects</subject><subject>pacing modality</subject><subject>reprogramming</subject><subject>Retrospective Studies</subject><subject>Time Factors</subject><issn>0147-8389</issn><issn>1540-8159</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><recordid>eNqVkM1O4zAUhS0EgtLhEZAiFuwSbCf-YwVtgaJpZxhpEGJl2c6t5JKfEqeinacnVaruxxsvzrmfrz-ErghOSHdulglhGY4lYSohSsqktZinVCabIzQ4RMdogEkmYplKdYbOQ1hijDnO2Ck6pRlPGecD9D6ZTKIX46A0H9CEaG42vvT_IJpCWefbypTeRSOoYOHbEJkqj-a-6hvjulwV3pnW11WIFnUTzevQdrDWQ9WGH-hkYYoAF_t7iF4fH_6Op_Hs99Pz-H4WuwwrEnPDXaqE6VaQnEueZ1RyKzJqc6oYk84pbKXNpaXQ_dIyyoSQ1nGFqQSapUN03XNXTf25htDq0gcHRWEqqNdBC8mU4CTtird90TV1CA0s9KrxpWm2mmC986qXeidP7-TpnVe996o33fDl_pW1LSE_jO5Fdvldn3_5Arb_QdYv9-MHogjpEHGP8KGFzQFhmg_NRSqYfvv1pMnjT_5nOmIap9_iX5do</recordid><startdate>198811</startdate><enddate>198811</enddate><creator>BYRD, CHARLES L.</creator><creator>SCHWARTZ, SUSAN J.</creator><creator>GONZALES, MICHELE</creator><creator>BYRD, CHARLES B.</creator><creator>CIRALDO, ROBERT J.</creator><creator>SIVINA, MANUEL</creator><creator>YAHR, WILLIAM Z.</creator><creator>GREENBERG, JACK J.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198811</creationdate><title>DDD Pacemakers Maximize Hemodynamic Benefits and Minimize Complications for Most Patients</title><author>BYRD, CHARLES L. ; SCHWARTZ, SUSAN J. ; GONZALES, MICHELE ; BYRD, CHARLES B. ; CIRALDO, ROBERT J. ; SIVINA, MANUEL ; YAHR, WILLIAM Z. ; GREENBERG, JACK J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4091-6a6c397aace86686d4286b742bd29558cc90b8bd8b2eb06b525778bc69028e243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>atrial fibrillation</topic><topic>Cardiac Pacing, Artificial - methods</topic><topic>cummulative survival</topic><topic>DDD pacemaker</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Hemodynamics</topic><topic>Humans</topic><topic>loss of atrial sensing</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Pacemaker, Artificial - adverse effects</topic><topic>pacing modality</topic><topic>reprogramming</topic><topic>Retrospective Studies</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BYRD, CHARLES L.</creatorcontrib><creatorcontrib>SCHWARTZ, SUSAN J.</creatorcontrib><creatorcontrib>GONZALES, MICHELE</creatorcontrib><creatorcontrib>BYRD, CHARLES B.</creatorcontrib><creatorcontrib>CIRALDO, ROBERT J.</creatorcontrib><creatorcontrib>SIVINA, MANUEL</creatorcontrib><creatorcontrib>YAHR, WILLIAM Z.</creatorcontrib><creatorcontrib>GREENBERG, JACK J.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pacing and clinical electrophysiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BYRD, CHARLES L.</au><au>SCHWARTZ, SUSAN J.</au><au>GONZALES, MICHELE</au><au>BYRD, CHARLES B.</au><au>CIRALDO, ROBERT J.</au><au>SIVINA, MANUEL</au><au>YAHR, WILLIAM Z.</au><au>GREENBERG, JACK J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DDD Pacemakers Maximize Hemodynamic Benefits and Minimize Complications for Most Patients</atitle><jtitle>Pacing and clinical electrophysiology</jtitle><addtitle>Pacing Clin Electrophysiol</addtitle><date>1988-11</date><risdate>1988</risdate><volume>11</volume><issue>11</issue><spage>1911</spage><epage>1916</epage><pages>1911-1916</pages><issn>0147-8389</issn><eissn>1540-8159</eissn><abstract>A 44‐month retrospective analysis was performed on 666 pacemakers implanted at Mt. Sinai Medical Center. Mapping techniques and endocardial waveform analyses were used during lead positioning to ensure the best electrical environment. The optimal pacing lead type was selected based on the clinical situation. Follow‐up evaluations were rigorous. Patient population ranged in age from 28 to 103 with a mean of 78 years at time of implant. Seventy percent of the patients received DDD pacemakers with an 81% survival incidence at 44 months, of the WI population (30% of the implants), there was a 62% survival incidence. Most problems associated with the pacing systems were related to the atrial channel. Loss of atrial sensing occurred in 7.5% of the population and was corrected noninvasively in 5.8%. Due to chronic loss of atrial sensing, 1.7% of the population remained programmed to DVI/VVI. A total of 7.7% were chronically reprogrammed from DDD to WI, 5.6% secondary to atrial fibrillation. Reoperations were necessary in 1.2% of the malfunctioning systems that could not be corrected by reprogramming. The following conclusions were reached: (1) maximizing hemodynamic benefits and minimizing pacemaker complications permitted a survival rate equal to or better than that of the general population, and (2) chronic problems related to the atrial lead and malfunctions of the pacing system were minimized by careful patient selection, appropriate pacemaker and lead selection, endocardial waveform analysis, and thorough follow‐up.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>2463566</pmid><doi>10.1111/j.1540-8159.1988.tb06328.x</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0147-8389
ispartof Pacing and clinical electrophysiology, 1988-11, Vol.11 (11), p.1911-1916
issn 0147-8389
1540-8159
language eng
recordid cdi_proquest_miscellaneous_78597613
source SPORTDiscus
subjects Adult
Aged
Aged, 80 and over
atrial fibrillation
Cardiac Pacing, Artificial - methods
cummulative survival
DDD pacemaker
Female
Follow-Up Studies
Hemodynamics
Humans
loss of atrial sensing
Male
Middle Aged
Pacemaker, Artificial - adverse effects
pacing modality
reprogramming
Retrospective Studies
Time Factors
title DDD Pacemakers Maximize Hemodynamic Benefits and Minimize Complications for Most Patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T01%3A32%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DDD%20Pacemakers%20Maximize%20Hemodynamic%20Benefits%20and%20Minimize%20Complications%20for%20Most%20Patients&rft.jtitle=Pacing%20and%20clinical%20electrophysiology&rft.au=BYRD,%20CHARLES%20L.&rft.date=1988-11&rft.volume=11&rft.issue=11&rft.spage=1911&rft.epage=1916&rft.pages=1911-1916&rft.issn=0147-8389&rft.eissn=1540-8159&rft_id=info:doi/10.1111/j.1540-8159.1988.tb06328.x&rft_dat=%3Cproquest_cross%3E78597613%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4091-6a6c397aace86686d4286b742bd29558cc90b8bd8b2eb06b525778bc69028e243%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78597613&rft_id=info:pmid/2463566&rfr_iscdi=true